HIV in the News

Published on: July 31, 2015
An updated version of Viread (tenofovir) offers slightly better viral suppression and improves indicators of kidney and bone health, compared with the current version of the drug.
Published on: July 30, 2015
A program in San Francisco has succeeded in getting people on antiretroviral treatment the day they are diagnosed with HIV and in shortening the time until they have an undetectable viral load.
Published on: July 30, 2015
Researchers have charted how HIV has affected older generations of gay men in the Seattle area worse than their younger counterparts and how, in more recent years, racial disparities have emerged.
Published on: July 29, 2015
Just 7 percent of American youths recently diagnosed with HIV achieved an undetectable viral load during a two-year study.
Published on: July 29, 2015
Crystal meth use among gay men in King County, Washington, which includes Seattle, accounts for an estimated 16 percent of new HIV transmissions.
Published on: July 28, 2015
HIV uses a viral protein to manipulate the immune system into suppressing natural antiviral responses so it can more easily establish an infection.
Published on: July 28, 2015
A program that offered cash incentives for girls living in a poor section of South Africa failed to lower the HIV infection rate among them.
Published on: July 27, 2015
Among HIV-positive people, it is preferable to treat hepatitis B with a two-drug regimen rather than with monotherapy.
Published on: July 27, 2015
Merck’s next-generation NNRTI doravirine (MK-1439) suppresses HIV as well as Sustiva (efavirenz) and leads to half the rate of side effects.
Published on: July 27, 2015
Young gay and bisexual men adhered moderately well to PrEP in a recent trial, but adherence dropped over time and was very poor among black and mixed-race participants.

Pages